Literature DB >> 22293497

Parametric [11C]flumazenil images.

Ursula M H Klumpers1, Ronald Boellaard, Dick J Veltman, Reina W Kloet, Witte J G Hoogendijk, Adriaan A Lammertsma.   

Abstract

OBJECTIVE: This [11C]flumazenil (FMZ) study evaluates the performance of various parametric analysis methods and their ability to detect statistically significant group differences.
METHODS: Dynamic 60-min FMZ scans were performed in eight healthy and nine individuals with major depressive disorder. Parametric volume of distribution (VT) images were generated using a basis function method (BFM) implementation of the single tissue compartment model (1T) and Logan plot analysis, both with a metabolite-corrected arterial plasma input function. Parametric binding potential (BP ND) images were generated using multilinear reference tissue methods (MRTM0-4), reference Logan and receptor parametric mapping (RPM1-2), with pons as a reference region. Standardized uptake value (SUV) and SUV ratio-to-pons (SUVr) images were calculated over the time interval 30-40 and 20-60 min postinjection. The resulting VT, BP ND, SUV and SUVr values were compared with nonlinear regression values, using both the 1T model and the simplified reference tissue model. Statistical parametric mapping (SPM5) was used to detect group differences, with an emphasis on the bilateral parahippocampal gyri.
RESULTS: BFM was more accurate than Logan, but showed more variability. Both RPM methods and MRTM2 showed the best average correlation with the simplified reference tissue model. In using SPM, SUV and SUVr images provided the best contrast between groups in the parahippocampal gyri, but provided large underestimation and overestimation in quantitative comparisons. BFM and RPM methods allowed for the determination of perfusion effects.
CONCLUSION: Parametric Logan VT, MRTM2 and RPM1-2 BP ND methods allow the best quantitative comparison of FMZ binding between groups and show good discriminating performance in SPM analysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22293497     DOI: 10.1097/MNM.0b013e3283505f7b

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  3 in total

1.  External awareness and GABA--a multimodal imaging study combining fMRI and [18F]flumazenil-PET.

Authors:  Christine Wiebking; Niall W Duncan; Pengmin Qin; Dave J Hayes; Oliver Lyttelton; Paul Gravel; Jeroen Verhaeghe; Alexey P Kostikov; Ralf Schirrmacher; Andrew J Reader; Malek Bajbouj; Georg Northoff
Journal:  Hum Brain Mapp       Date:  2012-09-21       Impact factor: 5.038

2.  Parametric Imaging of [11C]Flumazenil Binding in the Rat Brain.

Authors:  Isadora Lopes Alves; David Vállez García; Andrea Parente; Janine Doorduin; Ana Maria Marques da Silva; Michel Koole; Rudi Dierckx; Antoon Willemsen; Ronald Boellaard
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

3.  Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods.

Authors:  Mark R Battle; Lovena Chedumbarum Pillay; Val J Lowe; David Knopman; Bradley Kemp; Christopher C Rowe; Vincent Doré; Victor L Villemagne; Christopher J Buckley
Journal:  EJNMMI Res       Date:  2018-12-05       Impact factor: 3.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.